Browsing Category

24268 posts

HKeybio Launches World's First NHP Hidradenitis Suppurativa Model with High Clinical Consistency to Tackle Global Drug R&D Bottleneck

BOSTON and SUZHOU, China, April 21, 2026 /PRNewswire/ — HKeybio Tech., a global…
DIFC to become the world's first AI-Native financial centre

DIFC to become the world's first AI-Native financial centre

DUBAI, UAE, April 21, 2026 /PRNewswire/ — The Dubai International Financial Centre (DIFC),…

Connect & Influence 2026 Opens in Kuala Lumpur, Charting the Future of Corporate Communications

About the Conference Connect & Influence 2026 Opens in Kuala Lumpur, Charting…
2026 Geely Auto International Business Partner Conference Opens in Hangzhou, "One Geely" Strategy Accelerates Global Development

2026 Geely Auto International Business Partner Conference Opens in Hangzhou, "One Geely" Strategy Accelerates Global Development

HANGZHOU, China, April 21, 2026 /PRNewswire/ — Geely Auto is hosting its 2026…
Bybit Introduces Premier Loans, Democratizing Enterprise-Grade Capital Solutions

Bybit Introduces Premier Loans, Democratizing Enterprise-Grade Capital Solutions

DUBAI, UAE, April 21, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency…
Cognizant joins J.P. Morgan Payments Consultant Implementation Program

Cognizant joins J.P. Morgan Payments Consultant Implementation Program

Clients can leverage Cognizant to accelerate implementation of J.P. Morgan Payments solutions…
Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of 6 Million, Includes Million OpenAI, Million MrBeast, More Than 11,000 ETH Coins and Over 283 Million WLD Tokens

Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of $336 Million, Includes $90 Million OpenAI, $25 Million MrBeast, More Than 11,000 ETH Coins and Over 283 Million WLD Tokens

Eightco treasury composition as of April 20, 2026: $90M OpenAI equity, $25M…

Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program

Five-year collaboration supports consistent clinical supply for Phase 1A/1B GI cancer study…